DOI QR코드

DOI QR Code

Effects of Radiation Mutant Perilla frutescens var. crispa in Preventing and Alleviating Symptoms in a Monosodium Iodoacetate-Induced Osteoarthritis Rat Model

MIA로 퇴행성관절염을 유도한 랫드에 방사선 형질전환 차조기가 증상 예방 및 완화에 미치는 효과

  • 심부용 (중부대학교 바이오융합학부) ;
  • 주인환 (대전대학교 한의과대학) ;
  • 김성규 ((주)에스에프씨바이오) ;
  • 지중구 (중부대학교 한방보건제약학과)
  • Received : 2020.08.06
  • Accepted : 2020.08.25
  • Published : 2020.08.31

Abstract

The present study aimed to evaluate the effect of radiation mutant Perilla frutescens var. crispa on bone metabolism and the inflammatory response in a monosodium iodoacetateinduced rat model of osteoarthritis. radiation mutant Perilla frutescens var. crispa was administered orally at doses of 25, 50 or 100 mg/kg/day for 2 weeks before direct injection of monosodium iodoacetate (3 mg/50 μl of 0.9% saline) into the intra-articular space of the rats' right knees. The rats subsequently received the same doses of oral radiation mutant Perilla frutescens var. crispa for another 4 weeks. It was evaluated that the treatment effects based on serum biomarkers, and morphological and histopathological analysis of the knee joints. Compared with those in control rats, the radiation mutant Perilla frutescens var. crispa treatments significantly reduced the serum levels of inflammation, bone metabolism markers (i.e., COX-2, LTB4, MMP-3, and COMP), and the amount of fibrous tissue. Otherwise, it was significantly increased the concentration of TIMP-1 and calcitonin. In addition, the radiation mutant Perilla frutescens var. crispa treatments effectively preserved the knee cartilage and synovial membrane. As a result, it indicates that radiation mutant Perilla frutescens var. crispa prevented and alleviated osteoarthritis symptoms. Thus, radiation mutant Perilla frutescens var. crispa can be used in food and drug material for the management of osteoarthritis.

본 연구는 MIA로 퇴행성관절염을 유도한 랫드에 방사선 형질전환 차조기가 골 대사 및 염증 반응에 미치는 효과를 평가하였다. 방사선 형질전환 차조기를 2주 동안 25, 50, 100 mg/kg/day의 용량으로 경구 투여하고 랫드의 우측 관절 내 공간에 MIA를 주입하였다. 이후 동일한 용량을 4주 동안 지속 투여하였다. 혈청 바이오마커와 무릎 관절 분석의 형태학 및 조직병리학적 분석에 기초한 치료 효과를 평가하였다. 대조군 랫드와 비교하였을 때 방사선 형질전환 차조기는 혈청 내 염증 및 골 대사 마커(COX-2, LTB4, MMP-3, COMP)의 생성량을 유의하게 감소시켰다. 이와는 다르게 TIMP-1 및 calcitonin의 생성이 크게 증가하였다. 또한, 방사선 형질전환 차조기는 무릎 연골과 활막을 효과적으로 보존하였다. 그 결과, 방사선 형질전환 차조기는 퇴행성관절염 증상을 예방하고 완화였다. 따라서, 방사선 형질전환 차조기는 퇴행성관절염 관리를 위한 식·의약품 소재로 사용될 수 있다.

Keywords

References

  1. National Statistical Office(NSO), Statistics of Senior Citizens, (2019).
  2. National Health Insurance Service, Korean Statistical Information Service [Internet], Available From: http://kosis.kr/statHtml/statHtml.do?orgId=350&tblId=DT_35001_A074111&conn_path=I2. (accessed Dec., 18, 2019).
  3. S. Glyn-Jones, A. J. R. Palmer, R. Agricola, A. J. Price, T. L. Vincent, H. Weinans, A. J. Carr, "Osteoarthritis", The Lancet, Vol. 386, No. 9991, pp. 376-387, (2015). https://doi.org/10.1016/S0140-6736(14)60802-3
  4. B. J. Park, H. J. Choi, B. Y. Sim, M. Y. Yun, I. H. Yoo, D. H. Kim, "Effects of KV Pharmacopuncture on MIA-induced Osteoarthritis Rat", Journal of Physiology & Pathology in Korean Medicine, Vol. 31, No. 1, pp. 46-51, (2017). https://doi.org/10.15188/kjopp.2017.02.31.1.46
  5. W. Zhang, G. Nuki, R. W. Moskowitz, S. Abramson, R. D. Altman, N. K. Arden, M. Dougados, "OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009", Osteoarthritis and cartilage, Vol. 18, No. 4, pp. 476-499, (2010). https://doi.org/10.1016/j.joca.2010.01.013
  6. A. Ghouri, P. G. Conaghan, "Prospects for Therapies in Osteoarthritis", Calcified Tissue International, 1-12. (2020).
  7. Y. I. Lee, I. C. Shin, I. K. Lee, D. S. Kim, "Variation of Leaf Pigment Contents in Progenies of Perilla Mutants Induced by Gamma Ray", Plant Breeding & Biotechnology, Vol. 31, No. 2, pp. 110-113, (1999).
  8. M. Hosoi, M. Ito, T. Yagura, R. P. Adams, G. Honda, "cDNA isolation and functional expression of myrcene synthase from Perilla frutescens", Biological and Pharmaceutical Bulletin, Vol. 27, No. 12, pp. 1979-1985. (2004). https://doi.org/10.1248/bpb.27.1979
  9. C. H. Jin, H. J. Lee, Y. D. Park, D. S. Choi, D. S. Kim, S. Y. Kang, I. Y. Jeong, "Isoegomaketone inhibits lipopolysaccharideinduced nitric oxide production in RAW 264.7 macrophages through the heme oxygenase-1 induction and inhibition of the interferon-$\beta$-STAT-1 pathway", Journal of agricultural and food chemistry, Vol. 58, No. 2, pp. 860-867, (2009). https://doi.org/10.1021/jf9033333
  10. B. O. Cho, C. H. Jin, Y. D. Park, H. W. Ryu, M. W. Byun, K. I. Seo, I. Y. Jeong, "Isoegomaketone induces apoptosis through caspase-dependent and caspase-independent pathways in human DLD1 cells", Bioscience, biotechnology, and biochemistry, Vol. 75, No. 7, pp. 1306-1311, (2011). https://doi.org/10.1271/bbb.110088
  11. B. Y. Sim, J. H. Park, S. K. Kim, J. G. Ji, "Effects of anti-inflammatory on Perilla frutescens var. crispa Induced by mutants with $\gamma$-Ray". Journal of the Korean Applied Science and Technology, Vol. 36, No. 2, pp. 488-497, (2019). https://doi.org/10.12925/JKOCS.2019.36.2.488
  12. M. H. Park, C. J. Kim, J. Y. Lee, C. Y. Keum, I. S. Kim, C. H. Jin, S. K. Kim, "Anti-Arthritic Effect of Radiation Mutant Perilla frutescens var. crispa and Atractylodes macrophala koidz", Journal of the Korean Applied Science and Technology, Vol. 37, No. 1, pp. 102-113, (2020).
  13. S. Y. Jin, S. S. Kang, D. W. Lee, S. J. Yim, Y. H. Yun, B. I. Lee, "Expression of Matrix Metalloproteinase (MMP)-1, MMP-3 Nitrotyrosine and Apoptosis in Articular Cartilage of Human Osteoarthritis", The Korean Journal of Pathology, Vol. 35, No. 4, pp. 319-329, (2001).
  14. I. Pengas, S. Eldridge, A. Assiotis, M. McNicholas, J. E. Mendes, L. Laver, "MMP-3 in the peripheral serum as a biomarker of knee osteoarthritis, 40 years after open total knee meniscectomy", Journal of experimental orthopaedics, Vol. 5, No. 1, p. 21, (2018). https://doi.org/10.1186/s40634-018-0132-x
  15. M. Peters-Golden, W. R. Henderson Jr, "Leukotrienes", New England Journal of Medicine, Vol. 357, No. 18, pp. 1841-1854, (2007). https://doi.org/10.1056/NEJMra071371
  16. V. Karlapudi, A. V. V. Prasad Mungara, K. Sengupta, B. A. Davis, S. P. Raychaudhuri, "A placebo-controlled doubleblind study demonstrates the clinical efficacy of a novel herbal formulation for relieving joint discomfort in human subjects with osteoarthritis of knee", Journal of medicinal food, Vol. 21, No. 5, pp. 511-520, (2018). https://doi.org/10.1089/jmf.2017.0065
  17. G. D. Anderson, K. L. Keys, P. A. De Ciechi, J. L. Masferrer, "Combination therapies that inhibit cyclooxygenase-2 and leukotriene synthesis prevent disease in murine collagen induced arthritis", Inflammation Research, Vol. 58, No. 2, pp. 109-117, (2009). https://doi.org/10.1007/s00011-009-8149-3
  18. N. E. Lane, "Pain management in osteoarthritis: the role of COX-2 inhibitors", Journal of Rheumatology, Vol. 24, No. 49, pp. 20-24, (1997).
  19. M. Reijman, J. M. W. Hazes, S. M. A. Bierma-Zeinstra, B. W. Koes, S. Christgau, C. Christiansen, H. A. P. Pols, "A new marker for osteoarthritis: cross-sectional and longitudinal approach", Arthritis & Rheumatism: Official Journal of the American College of Rheumatology, Vol. 50, No. 8, pp. 2471-2478, (2004). https://doi.org/10.1002/art.20332
  20. M. A. Karsdal, B. C. Sondergaard, M. Arnold, C. Christiansen, "Calcitonin affects both bone and cartilage: a dual action treatment for osteoarthritis?", Annals of the New York Academy of Sciences, Vol. 1117, No. 1, pp. 181-195, (2007). https://doi.org/10.1196/annals.1402.041